India Sees Significant Boost in Rotavirus Vaccine Coverage

India's rotavirus vaccine coverage for children skyrocketed from 36.4% in 2019-2020 to 85.4% in 2023-24, according to NFHS-6. The introduction of the vaccine is part of the country's Universal Immunisation Programme, aiming to reduce rotavirus-induced diarrhoea cases.

India has achieved a remarkable enhancement in its rotavirus vaccine coverage for children, as highlighted by the latest National Family Health Survey (NFHS-6). The percentage of children receiving all three doses more than doubled, rising from 36.4% in 2019-21 to 85.4% in 2023-24.

The rotavirus vaccine was incorporated into India's Universal Immunisation Programme in 2016 and received nationwide rollout by 2019. This vaccine plays a crucial role in combating child mortality due to rotavirus-induced diarrhoea. The survey conducted by the Union Health Ministry further reveals a decline in Acute Respiratory Illness cases among children, attributed largely to the Pneumococcal Conjugate Vaccine introduced in 2017.

The survey indicates consistent progress in the overall vaccination coverage. NFHS-6 reports a gradual increase in the full immunisation coverage for children aged 12 to 23 months, reaching 87.1%. Significant strides were also observed in vaccinating against measles-rubella and pentavalent vaccine doses. The initiative remains supported by extensive government efforts and technological advancements in healthcare delivery.

Notably, these achievements have been recognized globally, distinguishing India as a leader in child health innovation. The UN Inter-Agency Group for Child Mortality Estimation commended India's reductions in under-five and neonatal mortality rates, outpacing global averages.